Encompass Health Corporation
EHC
$107.49
-$0.59-0.55%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.15% | 24.25% | 28.08% | 30.84% | 31.29% |
| Total Depreciation and Amortization | 8.91% | 9.45% | 9.53% | 12.44% | 10.06% |
| Total Amortization of Deferred Charges | -1.03% | -1.03% | 2.11% | 2.11% | 2.11% |
| Total Other Non-Cash Items | 19.49% | 23.95% | 28.34% | 24.72% | 21.38% |
| Change in Net Operating Assets | -237.50% | -80.37% | -164.76% | 631.11% | 48.15% |
| Cash from Operations | 14.01% | 17.23% | 19.83% | 26.71% | 22.15% |
| Capital Expenditure | -10.43% | -14.61% | -7.67% | -1.29% | -6.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.93% | -161.11% | -950.00% | -3,171.43% | -174.14% |
| Cash from Investing | -10.86% | -17.04% | -10.83% | -4.66% | -8.53% |
| Total Debt Issued | 442.86% | 121.05% | 161.54% | 110.00% | 5.00% |
| Total Debt Repaid | -33.24% | 29.08% | -45.46% | -291.06% | -118.84% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -175.42% | -312.04% | -204.75% | -209.52% | -558.73% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.10% | -13.22% | -13.84% | -10.54% | -6.92% |
| Other Financing Activities | -1,636.19% | -979.89% | -411.34% | 36.09% | 72.94% |
| Cash from Financing | 4.07% | -30.43% | -131.25% | -147.98% | -133.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 181.36% | -206.88% | -282.32% | -259.07% | -193.45% |